NCT01978327 GSK2647544 RD, DDI in Healthy Young and Elderly Volunteers Status TERMINATED Phase PHASE1
NCT01969136 Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Status TERMINATED Phase PHASE3
NCT01969123 Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Status TERMINATED Phase PHASE3
NCT01966666 A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TPI-287 in Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT01958437 Enhancing Spatial Navigation Using Non-Invasive Brain Stimulation Status COMPLETED Phase NA
NCT01955161 Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil Status COMPLETED Phase PHASE3
NCT01953601 Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019) Status TERMINATED Phase PHASE3
NCT01948791 16w Interventional Study on Titration and Dose/Efficacy Assessment of Exelon in Chinese Alzheimer's Disease Patients Status COMPLETED Phase PHASE4
NCT01928420 A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT01926691 Predictors for Poststroke Outcomes: Tel Aviv Brain Acute Stroke Cohort Acute Stroke Cohort (TABASCO) Status COMPLETED Phase N/A
NCT01924858 A Positron Emission Tomography (PET) Study to Investigate the Brain Biodistribution of 18F GSK2647544 in Healthy Subjects to Determine Its Ability to Cross the Blood-brain-barrier. Status TERMINATED Phase PHASE1
NCT01922258 Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Status COMPLETED Phase PHASE3
NCT01921972 The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease Status COMPLETED Phase PHASE4
NCT01920672 Disrupted Sleep, Neuroendocrine Status and the Behavioral Symptoms of AD Status COMPLETED Phase NA